Atrial Fibrillation Progression Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The objective of this study is to determine whether early radiofrequency (RF) ablation treatment, using the CARTO® 3 or CARTO® XP System, and THERMOCOOL® Catheter Family (including THERMOCOOL® SF or THERMOCOOL® SMARTTOUCH™) in subjects with paroxysmal atrial fibrillation (PAF), delays progression of atrial fibrillation (AF) compared with drug therapy (either rate or rhythm control) using current AF management guidelines.
Epistemonikos ID: 8edf121273b2ce305db454cbf954289004f7c982
First added on: May 10, 2024